PMID: 326642Jul 1, 1977Paper

Double-blind placebo-controlled study of loperamide (Imodium) in chronic diarrhoea caused by ileocolic disease or resection

Gut
P Mainguet, R Fiasse

Abstract

Loperamide (R 18 553) was compared with placebo in a double-blind crossover study of 21 patients with chronic diarrhoea caused by ileocolic disease or resection. Eighteen patients completed the trial. At a median daily dose of 6 mg the new antidiarrhoeal preparation was found to be superior to placebo in controlling chronic diarrhoea. The frequency and weight of stools significantly decreased, the stools became more solid, and carmine transit time was prolonged during loperamide therapy. Loperamide was consistently preferred to placebo by the patients. Gastrointestinal side-effects were few and comparable during both treatment periods.

References

Dec 31, 1975·Archiv für Psychiatrie und Nervenkrankheiten·B WoggonI Seibel
Jul 1, 1973·Journal of Medicinal Chemistry·R A StokbroekxP A Janssen
Feb 1, 1968·The Journal of Clinical Investigation·W E Meihoff, F Kern

Citations

Mar 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·U M Farack, K Loeschke
Mar 20, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·E Beubler, F Lembeck
Aug 1, 1977·The American Journal of Digestive Diseases·G N TytgatA van den Ende
Mar 1, 1984·Digestive Diseases and Sciences·I Altaparmakov, M Wienbeck
Mar 1, 1984·Digestive Diseases and Sciences·P A CannD Barends
Oct 24, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Alex ZhavoronkovAlexey Moskalev
Aug 29, 2000·Inflammatory Bowel Diseases·L B Gerson, G Triadafilopoulos
Mar 6, 2016·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Loris PironiHome Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN
May 1, 1996·Scandinavian Journal of Gastroenterology·P S EfskindM H Vatn
Aug 25, 2012·Gastroenterology Clinics of North America·Heimo H Wenzl
Oct 19, 2010·Gastroenterology Clinics of North America·Alexandra J Kent, M R Banks
Dec 23, 2015·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·B E Lacy
Dec 10, 2014·The American Journal of Gastroenterology·Charles N Bernstein
May 18, 2016·The Journal of Pharmacology and Experimental Therapeutics·John OberdickWolfgang Sadee
Mar 29, 2018·International Journal of Colorectal Disease·Jonathan YdeHanne B Moeller
May 21, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C HopeHjn Andreyev
Sep 1, 1995·The Journal of International Medical Research·M van Outryve, J Toussaint
Jan 13, 2021·Journal of Crohn's & Colitis·Bas P M VerhaeghLars K Munck
Dec 16, 2020·Best Practice & Research. Clinical Gastroenterology·David Lam, Oliver Jones

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.